This grant opportunity from the National Institute on Drug Abuse supports projects using Omics assays to explore how chronic substance use impacts the molecular regulation of persistent HIV, such as latency or reservoirs. Researchers can address outstanding questions in understanding HIV persistence within the context of substance use disorder. The closing date for applications is July 17, 2020, 12:00:00 AM EDT.
Opportunity ID: 300729
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-19-003 |
| Funding Opportunity Title: | Exploiting Omics Assays to Investigate Molecular Regulation of Persistent HIV in Individuals with Substance Use Disorder (R61/R33 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Feb 15, 2018 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Jul 17, 2020 |
| Current Closing Date for Applications: | Jul 17, 2020 |
| Archive Date: | Aug 22, 2020 |
| Estimated Total Program Funding: | $2,000,000 |
| Award Ceiling: | $450,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | State governments Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses City or township governments Public housing authorities/Indian housing authorities For profit organizations other than small businesses Special district governments Private institutions of higher education Independent school districts Others (see text field entitled “Additional Information on Eligibility” for clarification) County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This initiative will support projects that exploit Omics assays to address outstanding questions regarding molecular regulation of persistent HIV (e.g. latency or reservoirs) in the context of chronic substance use or substance use disorder (SUD). |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-19-003.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00238309 | Jun 17, 2018 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00260345 | Jun 17, 2018 | Jul 17, 2020 | View |
Package 1
Mandatory forms
300729 RR_SF424_2_0-2.0.pdf
300729 PHS398_CoverPageSupplement_4_0-4.0.pdf
300729 RR_OtherProjectInfo_1_4-1.4.pdf
300729 PerformanceSite_2_0-2.0.pdf
300729 RR_KeyPersonExpanded_2_0-2.0.pdf
300729 RR_Budget_1_4-1.4.pdf
300729 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
300729 RR_SubawardBudget30_1_4-1.4.pdf
300729 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
300729 RR_SF424_2_0-2.0.pdf
300729 PHS398_CoverPageSupplement_5_0-5.0.pdf
300729 RR_OtherProjectInfo_1_4-1.4.pdf
300729 PerformanceSite_2_0-2.0.pdf
300729 RR_KeyPersonExpanded_2_0-2.0.pdf
300729 RR_Budget_1_4-1.4.pdf
300729 PHS398_ResearchPlan_4_0-4.0.pdf
300729 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
300729 RR_SubawardBudget30_1_4-1.4.pdf
300729 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
